Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histologically-confirmed Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01715077
What this trial is testing

Study of Ipilimumab in the Immune System

Who this might be right for
Previously Untreated and Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma
University Health Network, Toronto 4
Early research (Phase 1)Study completedNCT00923182
What this trial is testing

A Safety Confirmatory Study of Alemtuzumab in Japanese Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Genzyme, a Sanofi Company 6
Large-scale testing (Phase 3)Study completedNCT03849118
What this trial is testing

89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study

Who this might be right for
Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 300
Testing effectiveness (Phase 2)Study completedNCT00753714
What this trial is testing

Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine

Who this might be right for
Non Small Cell Lung Cancer
Genzyme, a Sanofi Company 124
Testing effectiveness (Phase 2)Ended earlyNCT01601184
What this trial is testing

Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway

Who this might be right for
Histologically Confirmed MedulloblastomaActivation of the Sonic Hedgehog (SHH) Pathway
Centre Leon Berard 24
Not applicableActive Not RecruitingNCT07470827
What this trial is testing

Evaluation of 'WAYMED Endo CL CS' for Automated Detection and Diagnosis of Colorectal Adenoma and Non-Adenoma Lesions

Who this might be right for
Colorectal AdenomaSessile Serrated LesionHyperplastic Polyp+3 more
WAYCEN Inc 1,178
Large-scale testing (Phase 3)Study completedNCT05445167
What this trial is testing

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain

Who this might be right for
Uterine Fibroids (MeSH Heading: Leiomyoma)
Kissei Pharmaceutical Co., Ltd. 89
Not applicableLooking for participantsNCT06214611
What this trial is testing

Prospective Validation of Adaptive Radiotherapy (ART) in Patients With Head and Neck Tumors

Who this might be right for
Head and Neck CancerAdaptive RadiotherapyRadiation+3 more
University Hospital, Essen 50
Early research (Phase 1)Study completedNCT00528684
What this trial is testing

Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas

Who this might be right for
Malignant Glioma
Oncolytics Biotech 18
Early research (Phase 1)Study completedNCT01957007
What this trial is testing

Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC

Who this might be right for
Solid Tumors
OncoMed Pharmaceuticals, Inc. 34
Early research (Phase 1)Study completedNCT01608867
What this trial is testing

A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors

Who this might be right for
Solid Tumors
OncoMed Pharmaceuticals, Inc. 26
Early research (Phase 1)Study completedNCT01345201
What this trial is testing

A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors

Who this might be right for
Solid Tumors
OncoMed Pharmaceuticals, Inc. 35
Testing effectiveness (Phase 2)Study completedNCT00677716
What this trial is testing

Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse

Who this might be right for
Glioblastoma Multiforme
Peregrine Pharmaceuticals 41
Testing effectiveness (Phase 2)Ended earlyNCT02257684
What this trial is testing

A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
Jazz Pharmaceuticals 4
Testing effectiveness (Phase 2)UnknownNCT05902377
What this trial is testing

68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Peking Union Medical College Hospital 46
Not applicableStudy completedNCT01248000
What this trial is testing

The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy

Who this might be right for
Histologically Confirmed Classical Hodgkin Lymphoma According to the Current World Health Organisation Classification
Gruppo Italiano Studio Linfomi 136
Testing effectiveness (Phase 2)UnknownNCT05050630
What this trial is testing

Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL

Who this might be right for
Age Range ≥16 Years, Gender UnlimitedHistopathology Confirmed Diffuse Large B-cell Lymphoma or High-grade B-cell LymphomaReceived Prior First-line Chemotherapy for DLBCL or HGBL, Failed to Reach CR for Four Cycles, or Relapsed+4 more
Affiliated Hospital to Academy of Military Medical Sciences
Testing effectiveness (Phase 2)Active Not RecruitingNCT05406401
What this trial is testing

Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)

Who this might be right for
Lymphoma, Large B-Cell, Diffuse (DLBCL)
Merck Sharp & Dohme LLC 60
Testing effectiveness (Phase 2)Study completedNCT01207388
What this trial is testing

Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Amgen Research (Munich) GmbH 116
Not applicableLooking for participantsNCT04368702
What this trial is testing

CONFIRM: Magnetic Resonance Guided Radiation Therapy

Who this might be right for
Gastric CancerInvasive Breast Cancerin Situ Breast Cancer+3 more
Brigham and Women's Hospital 70
Next Page
73